Processing, please wait...

Ruthie AMIR

Industry representative

Ruthie Amir, MD, Chief Medical Officer, SofWave Medical, Alon Medtech Ventures

Dr. Ruthie Amir graduated from Ben Gurion University Medical School in 1989. From 1996-2000, she completed her post-doctoral fellowship in the Department of Human Genetic, at Baylor College of Medicine, Houston, USA where she worked on the genetic basis of Rett Syndrome. Between 200-2003 she completed a post-doctoral fellowship in the Department of Cell Biology, Faculty of Medicine, Technion.  From 2008-2017, she served as the director of clinical research and the head of the regulatory department of Syneron Candela.  In 2018, Dr. Ruthie Amir joined Alon-Medtech Ventures and as the chief medical officer.

read more
add item add Ruthie AMIR